Indo Tambangraya Megah Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Indo Tambangraya Megah Tbk trades at Rp26,100 (market cap 29.49T, 1.29M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indo Tambangraya Megah Tbk is far larger — about 282.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ITMG | SCPI | |
|---|---|---|
Market Cap | 29.49T | 104.4B |
Volume | 1.29M | — |
Lot | 12.91K | — |
Turnover | 33.85B | — |
Average Price | 26,216.62 | — |
Value | 33.85B | — |
Indicative Equilibrium Price | 26,100 | — |
Indicative Equilibrium Volume | 740 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Tambangraya Megah (the company) was established under its original name of PT Indotambangraya Megah base on notarial deed No.13 of Mr Benny Kristianto, SH, dated on Sep 2, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 33 dated 27 Jul 07 and No. 14 dated 22 Oct 07 of Fathiah Helmi concerning among others, the change in the Capital Structure, par value and public offering.
Read more on ITMG →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →